Search

everythinglearnresearchcommunity

for

Search:↓

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

The study explored a possible link between finasteride use and suicide.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Hair loss is a common side effect of hormone treatments for cancer.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Testosterone increases muscle mass regardless of DHT conversion blocking.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

The document covers various male health issues, their causes, treatments, and related conditions.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Stopping finasteride improves sperm quality but not semen volume in young men.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Dutasteride and finasteride affect different cell types differently.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.